FDA Clears the Path for BioVersys’ Phase 3 Trial i...
Category : Clinical Trial Update 18 March 2026Big milestone. High stakes. And a pathogen that refuses to play by the rules. BioVersys AG has just...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Bayer’s Finerenone Expands Its Reach in Chronic Ki...
Category : Clinical Trial Update 18 March 2026A big win. A broader patient pool. And a potential shift in how non-diabetic CKD is treated. Baye...
Lundbeck Advances Parkinson’s Pipeline with Promis...
Category : Clinical Trial Update 18 March 2026Early-stage data. New mechanisms. And a continued push into complex brain disorders. H. Lundbeck A/S...
Lilly Expands Ebglyss into Pediatric Eczema with S...
Category : Clinical Trial Update 18 March 2026A major milestone. A younger population. And a growing push into immunology leadership. Eli Lilly...
ONL Therapeutics Advances Global Trial for Vision...
Category : Clinical Trial Update 17 March 2026A key milestone has just been reached in the fight against one of the leading causes of blindness....
Latest Newsletter Post
-
Lilly Expands Ebglyss into Pediatri..
18 March 2026
-
Lundbeck Advances Parkinson’s Pipel..
18 March 2026
-
Bayer’s Finerenone Expands Its Reac..
18 March 2026
-
FDA Clears the Path for BioVersys’..
18 March 2026
-
Alzamend Neuro Launches Phase II Tr..
17 March 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com